{
    "clinical_study": {
        "@rank": "122609", 
        "arm_group": [
            {
                "arm_group_label": "Interscalene Block (ISB) - 0.375% Ropivacaine + additives", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Interscalene Block (ISB) - 0.2% Ropivacaine + additives", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Interscalene Block (ISB) - 0.1% Ropivacaine + additives", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Interscalene Block (ISB) - Systemic Control", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine which medication(s) should be included in the\n      interscalene nerve block (an injection of local anesthetic [numbing medicine] near nerves in\n      the shoulder) for patients undergoing total shoulder arthroplasty (shoulder replacement).\n      The ideal nerve block would reduce pain after shoulder surgery without causing a great deal\n      of muscle weakness."
        }, 
        "brief_title": "Analgesia After Total Shoulder Arthroplasty", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "condition": "Total Shoulder Arthroplasty", 
        "detailed_description": {
            "textblock": "All patients will receive an intravenous pain pump (patient-controlled analgesia) and a\n      nerve block with long-lasting local anesthetic. The three study groups will receive\n      additives (clonidine, dexamethasone, buprenorphine plus local anesthetic) in the nerve block\n      that may reduce postoperative pain. One of the study groups uses the usual concentration of\n      local anesthetic, while the other two study groups use reduced concentrations of local\n      anesthetic. Follow-up with study patients begins on the day of surgery and continues through\n      postoperative day 2. Seen twice daily, patients will be asked about their pain and assessed\n      for sensory function and strength of their shoulder muscle and hand grip."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with osteoarthritis\n\n          -  Primary total shoulder arthroplasty\n\n          -  Age 18 to 80 years old\n\n          -  Planned use of general anesthesia\n\n          -  Planned use of a brachial plexus nerve block for postoperative analgesia\n\n          -  Ability to follow study protocol\n\n        Exclusion Criteria:\n\n          -  Patients younger than 18 years old and older than 80\n\n          -  Allergy or intolerance to one of the study medications\n\n          -  Patients with an American Society of Anesthesiologists (ASA) physical status of IV\n\n          -  Patients with insulin-dependent diabetes\n\n          -  Patients with hepatic (liver) failure\n\n          -  Patients with chronic renal (kidney) failure\n\n          -  Bradycardia (heart rate < 50) or hypotension (systolic blood pressure < 90 mmHg)\n\n          -  Chronic opioid use (taking opioids for longer than 3 months) (or active diagnosis of\n             complex regional pain syndrome [CRPS]/reflex sympathetic dystrophy [RSD])\n\n          -  Lack of English fluency"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01782872", 
            "org_study_id": "2012-014"
        }, 
        "intervention": [
            {
                "arm_group_label": "Interscalene Block (ISB) - 0.375% Ropivacaine + additives", 
                "description": "Ultrasound-guided single-injection ISB: ropivacaine 0.375% + (clonidine [100 mcg] + dexamethasone [4 mg] + buprenorphine [150 mcg]); Intravenous (IV): saline", 
                "intervention_name": "Interscalene Block (ISB) - 0.375% Ropivacaine + additives", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Interscalene Block (ISB) - 0.2% Ropivacaine + additives", 
                "description": "Ultrasound-guided single-injection ISB: ropivacaine 0.2% + (clonidine [100 mcg] + dexamethasone [4 mg] + buprenorphine [150 mcg]); Intravenous: saline", 
                "intervention_name": "Interscalene Block (ISB) - 0.2% Ropivacaine + additives", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Interscalene Block (ISB) - 0.1% Ropivacaine + additives", 
                "description": "Ultrasound-guided single-injection ISB: ropivacaine 0.1% + (clonidine [100 mcg] + dexamethasone [4 mg] + buprenorphine [150 mcg]); Intravenous: saline", 
                "intervention_name": "Interscalene Block (ISB) - 0.1% Ropivacaine + additives", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Interscalene Block (ISB) - Systemic Control", 
                "description": "Ultrasound-guided single-injection ISB: ropivacaine 0.375%; Intravenous: clonidine (100 mcg) + dexamethasone (4 mg) + buprenorphine (150 mcg)", 
                "intervention_name": "Interscalene Block (ISB) - Systemic Control", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Ropivacaine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 20, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10021"
                }, 
                "name": "Hospital for Special Surgery"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Analgesia After Total Shoulder Arthroplasty", 
        "overall_official": {
            "affiliation": "Hospital for Special Surgery, New York", 
            "last_name": "Jacques T YaDeau, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Pain with movement at 24 hours from the nerve block (scale of 0-10; 0 = no pain, 10 = worst possible pain)", 
            "measure": "Numeric Rating Scale (NRS) Pain Score with Movement", 
            "safety_issue": "No", 
            "time_frame": "24 hours after the interscalene block is given"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01782872"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Patients will be asked about the duration of analgesia from an analgesic interscalene block at each visit until the block has resolved", 
                "measure": "Duration of Analgesia from Interscalene Nerve Block", 
                "safety_issue": "No", 
                "time_frame": "Postoperative day 1 at 8AM & 5PM, postoperative day 2 at 8AM & 5PM"
            }, 
            {
                "description": "Assessment of NRS pain scores (scale of 0-10; 0 = no pain, 10 = worst possible pain) at rest and with movement", 
                "measure": "Numeric Rating Scale (NRS) Pain Scores at Rest and with Movement", 
                "safety_issue": "No", 
                "time_frame": "Day of surgery (preop & 1-2 hours after arrival in the Post Anesthesia Care Unit), postoperative day 1 at 8AM & 5PM, postoperative day 2 at 8AM & 5PM"
            }, 
            {
                "description": "A physical assessment will be done to determine the strength of the middle deltoid muscle and hand grip in the operative arm using a dynamometer", 
                "measure": "Middle Deltoid & Hand Grip Strength", 
                "safety_issue": "No", 
                "time_frame": "Day of surgery (preop & 1-2 hours after arrival in the Post Anesthesia Care Unit), postoperative day 1 at 8AM & 5PM, postoperative day 2 at 8AM & 5PM"
            }
        ], 
        "source": "Hospital for Special Surgery, New York", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital for Special Surgery, New York", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}